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SETTING: Three health care facilities offering integrated TB-HIV care, Kibera, Nairobi  
OBJECTIVES: To report on the acceptability of cotrimoxazole prophylaxis and antiretroviral treatment 
(ART) among newly registered HIV-infected individuals with tuberculosis (TB). 
METHODS:  Review of TB registers and HIV data for the period January – December 2006. 
RESULTS: Out of a total of 361 newly registered TB patients, 247 (68%) were HIV-positive. This 
included 180(73%) cases of pulmonary TB(PTB) and 67(27%) cases of extra-pulmonary TB (EPTB). 
225(95%) HIV-TB co-infected individuals accepted cotrimoxazole for the prevention of opportunistic 
infections. Out of a total of 195 TB patients considered eligible for ART (EPTB, or PTB with a CD4 count 
<350 cells/ul), 20(10%) were transferred out, 7(4%)died, and 6(3%) defaulted before ART initiation.  Of 
the remaining 162 co-infected (ART eligible) patients still in the program, 125(77%) accepted ART along 
with anti-TB treatment while 21(13%) are still in the ART preparation phase. 16 (10%) patients refused  
ART.   
CONCLUSIONS: The high  uptake of cotrimoxazole and ART  in this resource-limited setting 
demonstrates the feasibility and value of an integrated approach to TB-HIV care and is of particular 
operational importance  given high HIV related mortality currently faced by TB programs in sub-Saharan 
Africa. 
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